Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
Experimental RNAi02:15

Experimental RNAi

6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

312
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
312

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Identifying Unmonitored Tone Drift in Patient Education Materials Transcribed to a Lower Reading Level by a Large Language Model.

Neurosurgery·2026
Same author

Machine learning and deep learning-based drug-drug interactions prediction: a systematic review focused on anticancer drugs.

NPJ precision oncology·2026
Same author

Gold Nanoparticles in Central Nervous System Diseases: Recent Progress, Challenges, and Therapeutic Opportunities.

Nano letters·2026
Same author

International multi-center study to quantify the effect of deep venous drainage after surgical resection of Spetzler-Martin Grade II-III brain arteriovenous malformations.

Neurosurgical review·2026
Same author

Cost-Effectiveness of Adjunctive Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: Secondary Analysis of EMBOLISE.

AJNR. American journal of neuroradiology·2026
Same author

Endovascular and Microsurgical Treatment for Middle Cerebral Artery Bifurcation Aneurysms: Experience From 10 High-Volume United States Cerebrovascular Centers.

Neurosurgery·2026
Same journal

Tracking Synthetic Adhesins on Bacterial Surfaces with Immunofluorescence Microscopy.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Post-Selection Methods for Analyzing mRNA Display Selections and Optimization of Hits.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

High-Performance Computing in Tandem Mass Spectrometry (MS/MS) Peptide Identification.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Engineering and Adapting Disulfide-Containing Proteins to Enable Intracellular Functionality.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

AI-Driven Protein Research: From Prediction to Design.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Methods for the In Vitro Selection of Protein and Peptide Libraries Using mRNA Display.

Methods in molecular biology (Clifton, N.J.)·2026
関連記事をすべて見る

関連する実験動画

Updated: Sep 9, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

791

免疫療法のためのアプタマー標的mRNAの開発

Alexandra R Paul1,2, Khuloud T Al-Jamal3,4

  • 1Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong SAR.

Methods in molecular biology (Clifton, N.J.)
|August 28, 2025
PubMed
まとめ
この要約は機械生成です。

この研究は,T細胞への標的メッセンジャーRNA (mRNA) 投与のための新しいアプタマー薬剤投与プラットフォームを導入しています. このプラットフォームは免疫細胞のmRNA伝染を大幅に強化し,免疫療法の可能性を向上させます.

キーワード:
アプタマーフローサイトメトリージェル電泳免疫療法核酸トランスフェクションmRNAの配送

さらに関連する動画

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

3.8K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.7K

関連する実験動画

Last Updated: Sep 9, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

791
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

3.8K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.7K

科学分野:

  • バイオテクノロジー
  • 免疫学
  • 薬物投与システム

背景:

  • メッセンジャーRNA (mRNA) の治療法は,選択的なタンパク質発現に依存しています.
  • mRNAを標的細胞,特に免疫細胞に効率的に送ることは,免疫療法にとって極めて重要です.
  • 現在のmRNA伝達方法はしばしば特異性がなく,治療効果を制限している.

研究 の 目的:

  • 免疫細胞へのmRNA配送の強化のための新しいT細胞標的アプタマー薬配送プラットフォームを開発し,検証する.
  • T細胞におけるアプタマー媒介 mRNA トランスフェクションの効率を免疫療法用で実証する.
  • アプタマー選択,結合,およびmRNA療法のための特徴付けのためのプロトコルを確立する.

主な方法:

  • T細胞を標的とするアプタマー選択と特徴付け.
  • アプタマーとOX40 mRNAの結合
  • アプタマー-mRNAをex vivoでマウンのT細胞に変換する.
  • CD4+およびCD8+T細胞におけるmRNA転移効率の定量化

主要な成果:

  • T細胞を標的にするアプタメルは,マウンのT細胞におけるmRNAトランスフェクションの効率を著しく高めました.
  • 標的でないmRNAと比較して,CD4+細胞の転移が4倍,CD8+細胞の転移が7倍増加した.
  • アプタマー- mRNA結合と特徴づけが成功しました.

結論:

  • 開発されたアプタマーベースのプラットフォームは,免疫療法のためのmRNAをT細胞に効率的に送ることができます.
  • この標的型投与アプローチは免疫細胞の感染を促進し,次世代のmRNA治療法に有望な戦略を提供します.
  • プラットフォームのモジュール化により,他の細胞タイプや受容体をターゲットにカスタマイズすることができます.